US$30M award for COVID-19 diagnostics
US National Institutes of Health (NIH) has awarded Ellume US$30million to accelerate the company’s range of COVID-19 antigen tests
Global partnership with QIAGEN for COVID-19 diagnosis
Ellume has partnered with global diagnostics company QIAGEN to bring fast, reliable COVID tests to market, addressing the global demand for rapid diagnostic tests.
Responding to the COVID-19 global pandemic
Ellume is developing next generation diagnostic products to address the current COVID-19 healthcare burden on our global community.
Digital diagnostic device for healthcare professionals
Offering a suite of fast, accurate diagnostic tests for common illnesses.
We have created the next generation of digital diagnostics
We develop, manufacture and commercialise the next generation of digital diagnostic products for clinicians and consumers.